https://orcid.org/0000-0002-1748-0990
Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Heui Min Lim & See-Hyoung Park. (2023) Regulation of reactive oxygen species by phytochemicals for the management of cancer and diabetes. Critical Reviews in Food Science and Nutrition 63:22, pages 5911-5936.
Read now
Read now
Yuying Ge, Yuying Chen, Chijiao Guo, Huan Luo, Fangda Fu, Weifeng Ji, Chengliang Wu & Hongfeng Ruan. (2022) Pyroptosis and Intervertebral Disc Degeneration: Mechanistic Insights and Therapeutic Implications. Journal of Inflammation Research 15, pages 5857-5871.
Read now
Read now
Articles from other publishers (37)
Zhi-lun Yu, Rui-yang Gao, Cheng Lv, Xiao-long Geng, Yi-jing Ren, Jing Zhang, Jun-yu Ren, Hao Wang, Fang-bin Ai, Zi-yi Wang, Bei-bei Zhang, Dong-hui Liu, Bei Yue, Zheng-tao Wang & Wei Dou. (2024) Notoginsenoside R1 promotes Lgr5+ stem cell and epithelium renovation in colitis mice via activating Wnt/β-Catenin signaling. Acta Pharmacologica Sinica.
Crossref
Crossref
Yu Yang, Jiwen Wu, Shicheng Feng, Hao Yu, Chuanxin Liu & Shuai Wang. (2024) Notoginsenoside R1 attenuates bupivacaine induced neurotoxicity by activating Jak1/Stat3/Mcl1 pathway. Toxicology 503, pages 153740.
Crossref
Crossref
Jun Yang, Kejun Ye, Rui Zhang, Xinrong Fan, Rui Xiong, Shiyu Zhang, Qiming Liu, Miao Lin, Bin Wang, Xiaoqiu Tan, Qiang Wen & Xianhong Ou. (2023) The characteristics and molecular targets of antiarrhythmic natural products. Biomedicine & Pharmacotherapy 168, pages 115762.
Crossref
Crossref
Jingjing Wang, Xun He & Shiwen Lv. (2023) Notoginsenoside‐R1 ameliorates palmitic acid‐induced insulin resistance and oxidative stress in HUVEC via Nrf2/ARE pathway. Food Science & Nutrition 11:12, pages 7791-7802.
Crossref
Crossref
Juan Wang, Yuwen Fang, Yongchun Zhou, Qin Chen, Jie Li, Yaxi Du, Xiuming Cui, Yuan Qu & Feng Ge. (2023) The main bioactive compound of Panax notoginseng, notoginsenoside R1, alleviates pulmonary fibrosis via MBD2/SHIP and STAT3 pathway. Journal of Functional Foods 110, pages 105881.
Crossref
Crossref
Caixia Pei, Nan Jia, Yilan Wang, Sijing Zhao, Zherui Shen, Shihua Shi, Demei Huang, Yongcan Wu, Xiaomin Wang, Shuiqin Li, Yacong He & Zhenxing Wang. (2023) Notoginsenoside R1 protects against hypobaric hypoxia-induced high-altitude pulmonary edema by inhibiting apoptosis via ERK1/2-P90rsk-BAD ignaling pathway. European Journal of Pharmacology 959, pages 176065.
Crossref
Crossref
Celia Bautista-Crescencio, Arturo Casimiro-Ramos, M. Jonathan Fragoso-Vázquez, José Correa-Basurto, Carlos Olano, César Hernández-Rodríguez & Lourdes Villa-Tanaca. (2023)
Streptomyces albidoflavus
Q antifungal metabolites inhibit the ergosterol biosynthesis pathway and yeast growth in fluconazole-resistant
Candida glabrata
: phylogenomic and metabolomic analyses
. Microbiology Spectrum 11:5.
Crossref
Crossref
Sijing Zhao, Nan Jia, Zherui Shen, Caixia Pei, Demei Huang, Junling Liu, Yilan Wang, Shihua Shi, Xiaomin Wang, Mingjie Wang, Yacong He & Zhenxing Wang. (2023)
Pretreatment with Notoginsenoside
R1
attenuates high‐altitude hypoxia‐induced cardiac injury via activation of the
ERK1
/
2‐P90RSK‐Bad
signaling pathway in rats
. Phytotherapy Research 37:10, pages 4522-4539.
Crossref
Crossref
Xianying Fang, Yuan Dai, Jingqiu Wang, Guoqin Guo, Xiangyang Ge & Linguo Zhao. (2023) Conversion by thermostable β-glucosidase Tpebgl3 improves the anti-tumor activity of Panax notoginseng saponins against breast cancer. Food Bioscience 54, pages 102734.
Crossref
Crossref
Xiaolei Fang, Jiayu Song, Kaixuan Zhou, Xue Zi, Bin Sun, Huiwei Bao & Lijing Li. (2023) Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease. Molecules 28:15, pages 5645.
Crossref
Crossref
Jing-jing Zeng, Han-qing Shi, Fang-fang Ren, Xiao-shan Zhao, Qiao-ying Chen, Dong-juan Wang, Lian-pin Wu, Mao-ping Chu, Teng-fang Lai & Lei Li. (2023) Notoginsenoside R1 protects against myocardial ischemia/reperfusion injury in mice via suppressing TAK1-JNK/p38 signaling. Acta Pharmacologica Sinica 44:7, pages 1366-1379.
Crossref
Crossref
Mohammad Mehdi Gravandi, Sadaf Abdian, Maedeh Tahvilian, Amin Iranpanah, Seyed Zachariah Moradi, Sajad Fakhri & Javier Echeverría. (2023) Therapeutic targeting of Ras/Raf/MAPK pathway by natural products: A systematic and mechanistic approach for neurodegeneration. Phytomedicine 115, pages 154821.
Crossref
Crossref
Siwei Li, Guoliang Pi, Yong Zeng, Changli Ruan, Xiaosong He, Xiaoxia Xiong, Man Zhang, Jiahua Zou & Xinjun Liang. (2022) Notoginsenoside R1 induces oxidative stress and modulates LPS induced immune microenvironment of nasopharyngeal carcinoma. International Immunopharmacology 113, pages 109323.
Crossref
Crossref
Sheng-lan Mei, Zhong-yuan Xia, Zhen Qiu, Yi-fan Jia, Jin-jian Zhou & Bin Zhou. (2022) Shenmai Injection Attenuates Myocardial Ischemia/Reperfusion Injury by Targeting Nrf2/GPX4 Signalling-Mediated Ferroptosis. Chinese Journal of Integrative Medicine 28:11, pages 983-991.
Crossref
Crossref
Yujiao Zheng, Jinbo Cheng, Chengjuan Gu, Mingzhong Xiao, Zuoyu Shao, Linhua Zhao & Xiaolin Tong. (2022) Case report: Treatment with Pien-Tze-Huang for prolonged positive SARS-CoV-2 test results in COVID-19 patients: A report of five cases. Frontiers in Medicine 9.
Crossref
Crossref
Han Li, Jing Zhu, Yan-wu Xu, Fang-fang Mou, Xiao-li Shan, Qiang-li Wang, Bao-nian Liu, Ke Ning, Jia-jia Liu, Ya-chao Wang, Jin-xia Mi, Xiaohui Wei, Shui-jin Shao, Guo-hong Cui, Rong Lu & Hai-dong Guo. (2022) Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. Redox Biology 54, pages 102384.
Crossref
Crossref
Lien Thi Ngo, Sung-yoon Yang, Jin-sung Yang, Ji hun Lee, Hwa-seung Yoo, Hwi-yeol Yun, Jin sook Song, So-jung Park & Jung-woo Chae. (2022) Fast Simultaneous Determination of 3 Major Components (Ginsenosides Rg1, Rb1, and Rc) after Oral Administration of HAD-B1 in Rats Using the HPLC-MS/MS System. Drug Targets and Therapeutics 1:1, pages 33-39.
Crossref
Crossref
Wei Lei, Yiqi Yan, Yaolei Ma, Min Jiang, Boli Zhang, Han Zhang & Yuhong Li. (2022) Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway. Frontiers in Pharmacology 13.
Crossref
Crossref
Yanwei Li, Qingwan Guo, Junqing Huang & Ziying Wang. (2022) Antidepressant Active Ingredients From Chinese Traditional Herb Panax Notoginseng: A Pharmacological Mechanism Review. Frontiers in Pharmacology 13.
Crossref
Crossref
Haiyan Wang, Yongyong Yan, Haifeng Lan, Nan Wei, Zhichao Zheng, Lihong Wu, Richard T. Jaspers, Gang Wu & Janak L. Pathak. (2022) Notoginsenoside R1 Promotes Migration, Adhesin, Spreading, and Osteogenic Differentiation of Human Adipose Tissue-Derived Mesenchymal Stromal Cells. Molecules 27:11, pages 3403.
Crossref
Crossref
Danli Jiao, Yang Liu, Tong Hou, Hao Xu, Xiaoyun Wang, Qi Shi, Yongjun Wang, Qiujuan Xing & Qianqian Liang. (2022) Notoginsenoside R1 (NG-R1) Promoted Lymphatic Drainage Function to Ameliorating Rheumatoid Arthritis in TNF-Tg Mice by Suppressing NF-κB Signaling Pathway. Frontiers in Pharmacology 12.
Crossref
Crossref
Xu Gong, Linlin Shan, Sisi Cao, Kaitao Li, Yanli Wu & Qing Zhang. (2022)
Notoginsenoside R1, An Active Compound from
Panax notoginseng
, Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis via MAPK Signaling Pathway
. The American Journal of Chinese Medicine 50:02, pages 511-523.
Crossref
Crossref
Z Jin, C Gan, G Luo, G Hu, X Yang, Z Qian & S Yao. (2021) Notoginsenoside R1 protects hypoxia-reoxygenation deprivation-induced injury by upregulation of miR-132 in H9c2 cells. Human & Experimental Toxicology 40:12_suppl, pages S29-S38.
Crossref
Crossref
Xumin Li, Haiyan Lin, Xiaorong Zhang, Richard T. Jaspers, Qihao Yu, Yinghui Ji, Tim Forouzanfar, Dongyun Wang, Shengbin Huang & Gang Wu. (2021) Notoginsenoside R1 attenuates oxidative stress‐induced osteoblast dysfunction through JNK signalling pathway. Journal of Cellular and Molecular Medicine 25:24, pages 11278-11289.
Crossref
Crossref
Jia-Rui ZHANG, Xuan OUYANG, Chi HOU, Qi-Feng YANG, Yingjun Wu, Wen-Ju LU, Chun-Li LIU, Kai YANG, Nan-Shan ZHONG, Jian WANG & Yu-Qin CHEN. (2021) Natural ingredients from Chinese materia medica for pulmonary hypertension. Chinese Journal of Natural Medicines 19:11, pages 801-814.
Crossref
Crossref
Di Liu, Zhenchen Zhao, Weidong Jiang, Peiqi Zhu, Xiaoning An, Yu Xie, Xuanping Huang & Nuo Zhou. (2021) Panax notoginseng Saponin Promotes Bone Regeneration in Distraction Osteogenesis via the TGF-β1 Signaling Pathway. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-11.
Crossref
Crossref
Ming Chen, Siqi Zhou, Liang Liu, Yinxian Wen & Liaobin Chen. (2021) Notoginsenoside R1 alleviates the inflammation of osteoarthritis by activating the Nrf2/HO-1 signalling pathway in vitro and in vivo. Journal of Functional Foods 85, pages 104666.
Crossref
Crossref
Xue Wang, Zhenhua Xie, Zhongguan Lou, Yulu Chen, Shuaishuai Huang, Yu Ren, Guobin Weng & Shuwei Zhang. (2021)
Regulation of the PTEN/PI3K/AKT pathway in RCC using the active compounds of natural products
in vitro
. Molecular Medicine Reports 24:5.
Crossref
Crossref
Zuqing Su, Yanru Guo, Xiufang Huang, Bing Feng, Lipeng Tang, Guangjuan Zheng & Ying Zhu. (2021) Phytochemicals: Targeting Mitophagy to Treat Metabolic Disorders. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
QuanYun Zhang, Li Zhou, Hong Xie, HongJin Zhang & XuZhu Gao. (2021) HAGLR aggravates neuropathic pain and promotes inflammatory response and apoptosis of lipopolysaccharide-treated SH-SY5Y cells by sequestering miR-182–5p from ATAT1 and activating NLRP3 inflammasome. Neurochemistry International 145, pages 105001.
Crossref
Crossref
Konghuai Wang, Danni Wu, Xuekun Ren, Qihao Yu, Ruona Liu, Shengbin Huang, Yihuai Pan & Shufan Zhao. (2021) Notoginsenoside R1 alleviates TEGDMA-induced mitochondrial apoptosis in preodontoblasts through activation of Akt/Nrf2 pathway-dependent mitophagy. Toxicology and Applied Pharmacology 417, pages 115482.
Crossref
Crossref
Minan Lu, Kegong Xie, Xianzhe Lu, Lu Lu, Yu Shi & Yujin Tang. (2020) Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling. Investigational New Drugs 39:2, pages 416-425.
Crossref
Crossref
Zhaohui Li, Liang Han, Qianlei Liang & Zhehao Huang. (2021) RETRACTED: Long noncoding RNA MEG3 contributes to dysfunction of brain microvascular endothelial cells after intracerebral hemorrhage by regulating the miR-1930-5p/Mllt1 axis. Brain Research Bulletin 166, pages 1-11.
Crossref
Crossref
Hui Li, Lianlian Fan, Yan Zhang, Yan Cao & Xin Liu. (2020) SNHG16 aggravates chronic constriction injury-induced neuropathic pain in rats via binding with miR-124-3p and miR-141-3p to upregulate JAG1. Brain Research Bulletin 165, pages 228-237.
Crossref
Crossref
Xiaodi Fan, Wenchao Bian, Meichen Liu, Jinjie Li & Yunyun Wang. (2020) WITHDRAWN: MiR-216b-5p attenuates chronic constriction injury-induced neuropathic pain in female rats by targeting MAL2 and inactivating Wnt/β-catenin signaling pathway. Neurochemistry International, pages 104930.
Crossref
Crossref
Fei Lin, Yu-Qing Tan, Xuan-Hui He, Li-Li Guo, Ben-Jun Wei, Jun-Ping Li, Zhong Chen, Heng-Wen Chen & Jie Wang. (2020) Huoxue Huatan Decoction Ameliorates Myocardial Ischemia/Reperfusion Injury in Hyperlipidemic Rats via PGC-1α–PPARα and PGC-1α–NRF1–mtTFA Pathways. Frontiers in Pharmacology 11.
Crossref
Crossref
Wenjie Long, Huili Liao, Xi Huang, Qingqing Liu, Yaqing Tang, Liming Lu, Jianhong Liu, Tianhui Yuan, Yan Ling, Yu Hong, Jiao Duan, Weiji Lin, Shaoxiang Xian & Zhongqi Yang. (2020) Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy. BMJ Open 10:8, pages e038074.
Crossref
Crossref